Olaparib activated the FOXM1 pathway as an adaptive cellular response to DNA damage, and FOXM1 inhibition enhanced sensitivity to PARPi in ES-2 and OVCA420 ovarian cancer cells 9. Here, FOXM1 is linked to ovarian cancer.